Multiple Sclerosis: Prognosis Better Than Expected
Medical News Today Tue, 04 Mar 2008 1:09 AM PST
The authors evaluated data on more than 5000 patients. 60% of MS patients aged 50 years could still walk a distance of 100 meters unaided, as could 40% of patients at age 60. These figures are better than previously assumed. This much more favorable prognosis has also been confirmed by other researchers.

Adult stem cell therapy generating excitement for treatment of disease
WSBT-TV - South Bend,IN,USA
A review of hundreds of trials found in some patients adult stem cells have stopped auto-immune diseases like rheumatoid arthritis and multiple sclerosis. ...
See all stories on this topic

'Now Hiring' not for all, disabled say
Tulsa World - Tulsa,OK,USA
Teter is unable to walk by herself and has spasms in her arm from multiple sclerosis. She said she discovered her condition in 1997, which worsened until ...
See all stories on this topic

Adult stem cell therapy generating excitement for treatment of disease
WSBT-TV - South Bend,IN,USA
A review of hundreds of trials found in some patients adult stem cells have stopped auto-immune diseases like rheumatoid arthritis and multiple sclerosis. ...
See all stories on this topic

Three Health-Care Stocks to Watch
Motley Fool - USA
That’s heading toward cheap -- if (and this is a big if) the company can put to rest the seizure issues that have occurred with fampridine. ...
See all stories on this topic

A Suspect Diagnosis
Washington Post Mon, 03 Mar 2008 8:47 PM PST
Whenever doctors told Ruben Galiano that his wife, Olga, had multiple sclerosis, he tried not to look as though he didn't believe them. To the former hotel cook, her symptoms resembled those he had seen in stroke patients. And the MS medication she had been taking hadn't done a thing.

Is modern life hurting human immunity?
The Wichita Eagle Tue, 04 Mar 2008 0:18 AM PST
First, asthma cases shot up, along with hay fever and other common allergic reactions, such as eczema. Then pediatricians started seeing more children with food allergies. Now experts are increasingly convinced that a suspected jump in lupus, multiple sclerosis and other afflictions caused by misfiring immune systems is real.
Though part of the increase may reflect better diagnoses, experts ...

PDL BioPharma Reports Fourth Quarter and Full Year 2007 Financial ...
CNNMoney.com - USA
... PDL earned and recognized a $5.0 million milestone payment from Biogen Idec related to the daclizumab CHOICE trial in multiple sclerosis. ...
See all stories on this topic

Bayer lowers drug unit's margin target after Yasmin legal defeat ...
Forbes - NY,USA
... raising the dosage of Betaseron improved the efficacy of the multiple sclerosis drug. Bayer today said it will 'consider its legal options' with regard ...
See all stories on this topic

A history of being innovative and fun
Boston Globe - United States
In a new paper she co-authored, Faustman argues that organs involved in autoimmune diseases
such as diabetes and multiple sclerosis play an accomplice role ...
See all stories on this topic

Adult stem cell therapy generating excitement for treatment of disease
WSBT-TV - South Bend,IN,USA
A review of hundreds of trials found in some patients adult stem cells have stopped auto-immune diseases like rheumatoid arthritis and multiple sclerosis. ...
See all stories on this topic

Merck Serono Launches New Formulation Of Interferon Beta-1a
Medical News Today Mon, 03 Mar 2008 1:05 PM PST
Merck Serono, a division of Merck KGaA, has announced that Rebif® New Formulation (interferon beta-1a) will be available in the UK. In a recent two-year (96 week) Phase IIIb study, 260 patients with relapsing remitting multiple sclerosis treated with the new formulation experienced a near three-fold reduction in injection-site reactions.

... Go to the Article
CancerWise - USA
Patients received the chemotherapy drugs fludarabine phosphate, cyclophosphamide (Cytoxan®) and rituximab for three days before transplantation. ...
See all stories on this topic